Literature DB >> 8431011

In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

J Vila1, A Marcos, F Marco, S Abdalla, Y Vergara, R Reig, R Gomez-Lus, T Jimenez de Anta.   

Abstract

Antimicrobial susceptibility testing was performed on 54 epidemiologically unrelated clinical isolates of Acinetobacter baumannii by using a standard agar dilution technique. On the basis of the in vitro activities, imipenem and doxycycline were the most active agents, whereas amikacin, isepamicin, and the new fluorquinolones ciprofloxacin and ofloxacin presented moderate activity. Cephalosporinase activity was found in 98% of the strains, whereas lactamases of TEM type 1 and one with a pI of 7 to 7.5 were present in 16 and 11% of the strains, respectively. Resistance to aminoglycosides was explained by the production of the three classes of aminoglycoside-modifying enzymes, with predominance of aminoglycoside-3'-phosphotransferase VI in 28% of the strains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431011      PMCID: PMC187622          DOI: 10.1128/AAC.37.1.138

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6).

Authors:  W H Traub; M Spohr
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 2.  Epidemiology of nosocomial infections due to Acinetobacter calcoaceticus.

Authors:  E Bergogne-Bérézin; M L Joly-Guillou; J F Vieu
Journal:  J Hosp Infect       Date:  1987-09       Impact factor: 3.926

Review 3.  Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies.

Authors:  J Sirot; C Chanal; A Petit; D Sirot; R Labia; G Gerbaud
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

4.  Distribution of beta-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus.

Authors:  M L Joly-Guillo; E Vallée; E Bergogne-Bérézin; A Philippon
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

5.  Resistance studies with ofloxacin.

Authors:  D Felmingham; P Foxall; M D O'Hare; G Webb; G Ghosh; R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

6.  Multiple intensive care unit outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated, reusable ventilator circuits and resuscitation bags.

Authors:  A I Hartstein; A L Rashad; J M Liebler; L A Actis; J Freeman; J W Rourke; T B Stibolt; M E Tolmasky; G R Ellis; J H Crosa
Journal:  Am J Med       Date:  1988-11       Impact factor: 4.965

7.  Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus.

Authors:  A W Chow; J Wong; K H Bartlett
Journal:  Diagn Microbiol Infect Dis       Date:  1988-04       Impact factor: 2.803

8.  Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains.

Authors:  J Vila; M Almela; M T Jimenez de Anta
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

9.  Transposon-mediated multiple antibiotic resistance in Acinetobacter strains.

Authors:  M Devaud; F H Kayser; B Bächi
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  [Nosocomial infections caused by Acinetobacter. Epidemiology and therapeutic difficulties].

Authors:  C Muller-Serieys; J B Lesquoy; E Perez; A Fichelle; B Boujeois; M L Joly-Guillou; E Bergogne-Berezin
Journal:  Presse Med       Date:  1989-01-28       Impact factor: 1.228

View more
  38 in total

1.  Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454.

Authors:  S Magnet; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates.

Authors:  G J Da Silva; G J Leitão; L Peixe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals.

Authors:  A Ribera; J Vila; F Fernández-Cuenca; L Martínez-Martínez; A Pascual; A Beceiro; G Bou; J M Cisneros; J Pachón; J Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

4.  AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters.

Authors:  Xian-Zhong Su; Jing Chen; Tohru Mizushima; Teruo Kuroda; Tomofusa Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 5.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 6.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

Review 7.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

8.  Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain.

Authors:  J Vila; J Ruiz; M Navia; B Becerril; I Garcia; S Perea; I Lopez-Hernandez; I Alamo; F Ballester; A M Planes; J Martinez-Beltran; T J de Anta
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.

Authors:  Jun Yong Choi; Chang Oh Kim; Yoon Seon Park; Hee Jung Yoon; So Youn Shin; Young Keun Kim; Myung Soo Kim; Yeon-A Kim; Young Goo Song; Dongeun Yong; Kyungwon Lee; June Myung Kim
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

10.  Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the Intensive care unit.

Authors:  Nidhi Goel; Uma Chaudhary; Ritu Aggarwal; Kiran Bala
Journal:  Indian J Crit Care Med       Date:  2009 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.